Afuco™ Anti-Human LILRA4 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-LILRA4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-ILT7 antibody binds to plasmacytoid dendritic cells (pDCs), a subset of dendritic cells (DCs). pDCs is known as a major source of IFNα; overproduction of IFNα is considered to be one of the major causes of autoimmune diseases. Anti-ILT7 antibody specifically recognizes and kills pDCs to suppress the IFNα supply, which leads to the improvement of autoimmune disease symptoms.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-471CL |
| Pricing | Inquiry |
| Host | Human |
| Target | LILRA4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |